204 related articles for article (PubMed ID: 22683628)
1. Cytoplasmic sequestration of the tumor suppressor p53 by a heat shock protein 70 family member, mortalin, in human colorectal adenocarcinoma cell lines.
Gestl EE; Anne Böttger S
Biochem Biophys Res Commun; 2012 Jun; 423(2):411-6. PubMed ID: 22683628
[TBL] [Abstract][Full Text] [Related]
2. Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein.
Wadhwa R; Yaguchi T; Hasan MK; Mitsui Y; Reddel RR; Kaul SC
Exp Cell Res; 2002 Apr; 274(2):246-53. PubMed ID: 11900485
[TBL] [Abstract][Full Text] [Related]
3. TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas.
Klaus C; Kaemmerer E; Reinartz A; Schneider U; Plum P; Jeon MK; Hose J; Hartmann F; Schnölzer M; Wagner N; Kopitz J; Gassler N
Cell Tissue Res; 2014 Jul; 357(1):267-78. PubMed ID: 24770931
[TBL] [Abstract][Full Text] [Related]
4. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
Wadhwa R; Takano S; Taira K; Kaul SC
J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
[TBL] [Abstract][Full Text] [Related]
5. Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model.
Walker C; Böttger S; Low B
Am J Pathol; 2006 May; 168(5):1526-30. PubMed ID: 16651619
[TBL] [Abstract][Full Text] [Related]
6. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
7. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis.
Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN
Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.
Bosari S; Viale G; Roncalli M; Graziani D; Borsani G; Lee AK; Coggi G
Am J Pathol; 1995 Sep; 147(3):790-8. PubMed ID: 7677190
[TBL] [Abstract][Full Text] [Related]
9. Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival.
Dundas SR; Lawrie LC; Rooney PH; Murray GI
J Pathol; 2005 Jan; 205(1):74-81. PubMed ID: 15532096
[TBL] [Abstract][Full Text] [Related]
10. Multiple p53 protein isoforms and formation of oligomeric complexes with heat shock proteins Hsp70 and Hsp90 in the human mammary tumor, T47D, cell line.
Selkirk JK; Merrick BA; Stackhouse BL; He C
Appl Theor Electrophor; 1994; 4(1):11-8. PubMed ID: 7811761
[TBL] [Abstract][Full Text] [Related]
11. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
[TBL] [Abstract][Full Text] [Related]
12. Natural state of mutant p53 protein and heat shock protein 70 in breast cancer tissues.
Iwaya K; Tsuda H; Fujita S; Suzuki M; Hirohashi S
Lab Invest; 1995 Jun; 72(6):707-14. PubMed ID: 7540234
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of the mitochondrial Hsp70 (mortalin)-p53 interaction using purified proteins--identification of additional interacting regions.
Iosefson O; Azem A
FEBS Lett; 2010 Mar; 584(6):1080-4. PubMed ID: 20153329
[TBL] [Abstract][Full Text] [Related]
14. Restoration of p53 functions by suppression of mortalin-p53 sequestration: an emerging target in cancer therapy.
Shankaranarayana AH; Meduri B; Pujar GV; Hariharapura RC; Sethu AK; Singh M; Bidye D
Future Med Chem; 2023 Nov; 15(22):2087-2112. PubMed ID: 37877348
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells.
Sane S; Abdullah A; Boudreau DA; Autenried RK; Gupta BK; Wang X; Wang H; Schlenker EH; Zhang D; Telleria C; Huang L; Chauhan SC; Rezvani K
Cell Death Dis; 2014 Mar; 5(3):e1118. PubMed ID: 24625977
[TBL] [Abstract][Full Text] [Related]
16. Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.
Manne U; Gary BD; Oelschlager DK; Weiss HL; Frost AR; Grizzle WE
Clin Cancer Res; 2001 Nov; 7(11):3495-503. PubMed ID: 11705868
[TBL] [Abstract][Full Text] [Related]
17. Expression of mortalin detected in human liver cancer by tissue microarrays.
Chen X; Xu B; Li H; Yang L; Zuo J; Liu W; Liu C
Anat Rec (Hoboken); 2011 Aug; 294(8):1344-51. PubMed ID: 21714113
[TBL] [Abstract][Full Text] [Related]
18. Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer.
Baltaziak M; Koda M; Wincewicz A; Sulkowska M; Kanczuga-Koda L; Sulkowski S
Anticancer Res; 2009 Oct; 29(10):4151-6. PubMed ID: 19846965
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adeno-oncolytic virus.
Yoo JY; Ryu J; Gao R; Yaguchi T; Kaul SC; Wadhwa R; Yun CO
J Gene Med; 2010 Jul; 12(7):586-95. PubMed ID: 20603860
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
